Welcome to our dedicated page for Mirion Technologies news (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies stock.
Mirion Technologies, Inc. (NYSE: MIR) is a global provider of radiation detection, measurement, analysis, and monitoring solutions serving nuclear, medical, defense, and research end markets. This news page aggregates company press releases and third-party coverage so readers can follow how Mirion’s activities in radiation safety, science, and medicine develop over time.
Recent Mirion news has highlighted its role in the nuclear power sector and capital markets. The company announced a definitive agreement to acquire, and later the completion of the acquisition of, Paragon Energy Solutions, a provider of highly engineered solutions for large-scale nuclear power plants and small modular reactors in the United States. News releases describe how Paragon’s systems and solutions are present in all nuclear reactors in North America and how the acquisition is intended to broaden Mirion’s portfolio for nuclear power customers, including SMRs, within the Mirion Nuclear & Safety group.
Investors and observers can also find updates on Mirion’s financial performance and financing activities. The company issues quarterly earnings press releases, such as its announcement of third quarter 2025 results, and provides guidance commentary. Additional news covers public offerings of Class A common stock, convertible senior notes offerings, and related financing steps to support acquisitions and general corporate purposes.
Beyond transactions and earnings, Mirion’s news flow includes strategic collaborations. A notable example is its partnership agreement and practical arrangements with the International Atomic Energy Agency (IAEA) to cooperate in radiation detection and measurement, including support for the IAEA’s Terrestrial Environmental Radiochemistry Laboratory. For ongoing insight into MIR stock-related developments, nuclear and medical segment updates, and regulatory or partnership announcements, readers can review this news feed regularly.
Mirion Technologies (NYSE: MIR) has scheduled its first quarter 2025 financial results release for Tuesday, April 29, 2025, after market close. The company will host a conference call on Wednesday, April 30, 2025, at 11:00 am ET to discuss the quarterly performance.
Investors can join the earnings call by dialing 1-877-407-9208 (domestic) or 1-201-493-6784 (international). A live webcast will be available on the company's investor relations website. A replay of the call will be accessible until May 14, 2025, via phone using access code 13753466 or through Mirion's IR website.
Mirion Technologies (NYSE: MIR) has launched version 1.2 of its Apex-Guard gamma spectroscopy software, enhancing quality control in radiopharmaceutical production. The updated software introduces a patent-pending algorithm for Radionuclidic purity measurements, supporting compliance with FDA regulations.
The release comes amid rapid expansion in the radiopharmaceutical sector, with over 100 drugs in Phase I or further clinical development. The software builds upon Mirion's Genie™ and Apex-Gamma™ platforms, offering advanced controls, security, and audit features. It integrates with BioTrax QMS®, an electronic quality management system from ec2 Software, a Mirion Medical Company.
This enhancement aims to streamline quality management processes and ensure compliance in radioisotope production, particularly important for cancer care applications.
Mirion Technologies (NYSE: MIR) has secured contracts to provide critical systems for TerraPower's Natrium Reactor Demonstration Project in Wyoming, the first commercial advanced nuclear power plant in the U.S. The project, a public-private partnership between TerraPower and the U.S. Department of Energy, will implement Natrium technology combining a sodium-cooled fast reactor with molten salt energy storage.
Mirion will deliver two key systems:
- Radiation Monitoring System (RMS) featuring area, effluent, and process radiation monitors for continuous plant safety monitoring
- Nuclear Instrumentation System (XIS) for detecting reactor power levels
The contracts position Mirion to support innovative nuclear technologies, including small and advanced modular reactors, contributing to meeting modern energy demands with safe, sustainable nuclear power.
Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, has announced its membership in two major nuclear industry organizations. The company has joined the Nuclear Energy Institute (NEI) and enhanced its partnership with the American Nuclear Society (ANS) as a Trustees of Nuclear partner.
Through NEI membership, Mirion will participate in policy discussions shaping the nuclear industry and advocate for nuclear energy growth policies. As an ANS Trustee of Nuclear, the company will serve on its leadership council. CEO Thomas Logan emphasized Mirion's unique position across the nuclear landscape and its commitment to advancing the industry through these strategic partnerships.
Mirion Technologies (NYSE: MIR) has announced its participation in the 46th Annual Raymond James Institutional Investor Conference. The company's leadership team, including CEO Thomas Logan and CFO Brian Schopfer, will deliver a presentation scheduled for Wednesday, March 5, 2025, at 9:15 a.m. ET.
The presentation will be accessible through a live webcast on Mirion's Investor Relations Page under the 'Events and Presentations' section. An archived version of the webcast will also be made available at the same location for those unable to attend the live session.
Mirion Technologies (NYSE: MIR) has announced its participation in Citi's 2025 Global Industrial Tech and Mobility Conference in Miami, FL. The company's leadership, including CEO Thomas Logan and CFO Brian Schopfer, will deliver a presentation scheduled for Wednesday, February 19, 2025, at 2:40 PM ET.
Investors and interested parties can access the live webcast through Mirion's Investor Relations Page under the 'Events and Presentations' section. An archived version of the presentation will also be made available at the same location for those unable to attend the live event.
Mirion (NYSE: MIR) reported strong financial results for Q4 and full year 2024, with significant improvements across key metrics. Q4 revenues increased 10.4% to $254.3 million, while GAAP net income reached $15.9 million, marking a 210% improvement from the previous year's loss. The company achieved $69.6 million in Adjusted EBITDA, up 14.1% year-over-year.
For 2025, Mirion reaffirmed its guidance, projecting total revenue growth of 4.0-6.0% and organic revenue growth of 5.5-7.5%. The company expects Adjusted EBITDA between $215-230 million and introduced Adjusted EPS guidance of $0.45-0.50 per share. Notably, Mirion entered 2025 with approximately half of expected revenue already in backlog and is advancing discussions on $300-400 million in potential large orders.
Mirion Technologies (NYSE: MIR) has announced its schedule for the release of fourth quarter and full year 2024 financial results. The company will publish its results after market close on Tuesday, February 11, 2025, followed by a conference call on Wednesday, February 12, 2025, at 11:00 am ET.
Investors and interested parties can access the earnings call by dialing 1-877-407-9208 (US) or 1-201-493-6784 (International). A live webcast will be available on the company's investor relations website. A replay of the call will be accessible until February 26, 2025, using access code 13751221, and will also be archived on Mirion's investor website.
Mirion Technologies (NYSE: MIR) is hosting an Investor Day at the New York Stock Exchange to present its updated strategic and financial outlook. The company projects revenue of $1.1 billion by 2028, with 6-8% organic revenue growth, and targets an adjusted EBITDA margin of 30%. For 2025, Mirion forecasts organic revenue growth of 5.5-7.5% and adjusted EBITDA of $215-230 million. The company highlights its position in nuclear power and cancer care markets, announcing an anti-dilutive share repurchase program and updated capital allocation strategy. Management will discuss market opportunities in nuclear power growth, cancer care dynamics, and operational excellence initiatives.
Mirion Technologies (NYSE: MIR) has announced its participation in the Goldman Sachs' Industrials and Materials Conference in New York. CEO Thomas Logan and CFO Brian Schopfer will deliver a presentation on Thursday, December 5, 2024, at 10:40 AM ET. The event will be accessible via live webcast on Mirion's Investor Relations Page under the 'Events and Presentations' section, with an archived version available afterward.